Previous close | 36.00 |
Open | 36.00 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 36.00 - 36.00 |
52-week range | 32.72 - 37.78 |
Volume | |
Avg. volume | 30 |
Market cap | 7.856B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 18.27 |
EPS (TTM) | 1.97 |
Earnings date | N/A |
Forward dividend & yield | 1.41 (3.92%) |
Ex-dividend date | 27 Jun 2024 |
1y target est | N/A |
TOKYO, April 19, 2024--The AGC Group had announced that it will donate 3 million yen to help those affected by the eastern Taiwan Earthquake.
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. The new site is a part of the CDMO’s strategic growth strategy to create more high-quali